<DOC>
	<DOCNO>NCT00176202</DOCNO>
	<brief_summary>The study examine null hypothesis risperidone divalproex sodium equally effective treating/stabilizing pediatric bipolar disorder .</brief_summary>
	<brief_title>Risperidone Divalproex Sodium With MRI Assessment Pediatric Bipolar</brief_title>
	<detailed_description>Pediatric Bipolar Disorder ( PBD ) severely impairs child 's emotional development , associate alarm rate suicide , school failure , aggression , risk take behavior substance abuse ( Geller et al , 1998 ; 2001 ; Carlson et al , 1998 ) . At present , little known pathophysiology optimal treatment PBD . The long range goal proposal threefold : investigate range pharmacotherapeutic agent safe efficacious PBD , use fMRI technique examine abnormality brain function disorder , well change brain function treatment . In contrast adult literature , aware two prospective study assess efficacy standard mood stabilizer pediatric sample . In one , lithium find moderately effective PBD comorbid substance abuse ( Geller et al , 1998 ) . In , divalproex sodium , lithium carbamazepine produce maximum 50 % symptom reduction ( Kowatch et al , 2000 ) . Subsequently , Kafantaris et al ( 2001 ) observe potentiation lithium 's antimanic effect combine risperidone . Further , prospective , open trial olanzapine PBD report 70 % symptom reduction ( Frazier et al , 2001 ) retention rate 96 % compare 7 % classic mood stabilizer ( Kowatch et al , 2000 ) . Thus , parallel adult study ( Sachs et al , 2000 ) , novel antipsychotic promise treatment population . Further , 60 % acute PBD episode present psychotic feature ( Geller et al , press ) . Finally , time full effect mood stabilizer often 4 week child ( Kowatch et al , 2000 ; Geller et al , 1998 ; Kafantaris et al , 2001 ) , whereas antipsychotic usually rapid response onset ( Pavuluri et al , press ) . Given potential efficacy novel antipsychotic PBD , aim conduct randomize trial compare novel antipsychotic standard mood stabilizer :</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Children Bipolar Disorder Must able swallow tablet Children general medical condition head injury , epilepsy , endocrine disorder Those mood alter medication steroid , diagnose mental retardation exclude avoid confound contribute factor mood swing . If discover interview parent and/or child understand consent/assent procedure , exclude . We expect small number child exclude study due exclusionary criterion . Selection subject base sex , race , ethnic group .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>